Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Treatment should be discontinued after 12 weeks on the maintenance dose if patients have not lost at least 5% of their initial body weight
Any cell line may be affected, but thrombocytopenia seems to be a particular issue
The Tripeptide KPV Attenuates the Inflammatory Response. Journal of Pharmacology and Experimental Therapeutics
Risk and Handling Precautions Risk Tier: MODERATE This rating reflects both peptides' bioactive activity at angiogenic and cytoskeletal signaling pathways in preclinical models, the absence of established human safety profiles for either compound, and the additional handling considerations specific to intranasal formulations
It is commonly used as part of hormone replacement therapy (HRT) for individuals looking to support healthy aging, improve muscle mass, and enhance overall well-being
US$ 24.02
US$ 23.81
US$ 26.54
US$ 29.96
US$ 28.43
US$ 26.10
US$ 27.32
